KZR · CIK 0001645666 · operating
Kezar Life Sciences, Inc. (KZR) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $50 million, Kezar Life Sciences, Inc. is a micro-cap company. The stock currently trades at $7.03, up 4.93% today, with a 52-week range of $3.53–$6.86.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-11.49 | $-11.49 | -720.7% | |
| 2023 | $-1.40 | $-1.40 | -38.6% | |
| 2022 | $-1.01 | $-1.01 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-25 | 0001645666-25-000010 | SEC ↗ |
| 2023-12-31 | 2024-03-14 | 0000950170-24-031494 | SEC ↗ |
| 2022-12-31 | 2023-03-14 | 0000950170-23-007871 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0000950170-22-004085 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001564590-21-012525 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001564590-20-010498 | SEC ↗ |
| 2018-12-31 | 2019-03-26 | 0001564590-19-009369 | SEC ↗ |